This bill amends Section 37-2711 of the Idaho Code to classify the drugs Mifepristone and Misoprostol as Schedule IV substances. The inclusion of these drugs in this category indicates that they are considered to have a lower potential for abuse compared to substances in higher schedules, while still being regulated. The specific legal language added to the current law includes the insertion of Mifepristone and Misoprostol as items (4) and (5) under the "Other substances" subsection, while the previous item (4) has been renumbered to (6) as Pentazocine.

Additionally, the bill declares an emergency, allowing it to take effect on July 1, 2025. This expedited timeline suggests a sense of urgency regarding the regulation of these drugs, likely in response to ongoing discussions about reproductive health and access to medication.

Statutes affected:
Bill Text: 37-2711